HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,100,537 | +12.3% | 525,793 | +6.8% | 0.01% | +8.3% |
| Q2 2023 | $41,931,365 | +4.2% | 492,499 | +1.3% | 0.01% | 0.0% |
| Q1 2023 | $40,241,077 | +3.3% | 486,297 | -1.8% | 0.01% | -7.7% |
| Q4 2022 | $38,960,064 | +4.0% | 495,360 | -2.1% | 0.01% | 0.0% |
| Q3 2022 | $37,477,000 | +14.7% | 506,235 | +1.0% | 0.01% | +18.2% |
| Q2 2022 | $32,663,000 | +3.4% | 501,112 | +0.3% | 0.01% | +22.2% |
| Q1 2022 | $31,596,000 | +28.2% | 499,763 | +7.5% | 0.01% | +28.6% |
| Q4 2021 | $24,647,000 | -19.2% | 464,685 | +7.5% | 0.01% | -30.0% |
| Q3 2021 | $30,511,000 | +8.7% | 432,216 | +2.6% | 0.01% | +11.1% |
| Q2 2021 | $28,080,000 | -13.7% | 421,355 | +43.8% | 0.01% | -25.0% |
| Q1 2021 | $32,527,000 | -6.1% | 293,009 | +0.4% | 0.01% | -14.3% |
| Q4 2020 | $34,646,000 | +32.4% | 291,751 | -2.7% | 0.01% | +16.7% |
| Q3 2020 | $26,163,000 | -9.3% | 299,852 | -6.9% | 0.01% | -14.3% |
| Q2 2020 | $28,858,000 | -31.4% | 322,216 | -23.6% | 0.01% | -44.0% |
| Q1 2020 | $42,048,000 | -7.6% | 421,909 | +6.5% | 0.02% | +4.2% |
| Q4 2019 | $45,501,000 | -6.1% | 395,997 | +3.1% | 0.02% | -17.2% |
| Q3 2019 | $48,467,000 | -13.1% | 384,230 | -17.1% | 0.03% | -14.7% |
| Q2 2019 | $55,762,000 | +31.0% | 463,367 | -4.8% | 0.03% | +25.9% |
| Q1 2019 | $42,565,000 | -9.8% | 486,568 | +3.1% | 0.03% | -25.0% |
| Q4 2018 | $47,206,000 | -22.9% | 471,815 | -11.7% | 0.04% | -12.2% |
| Q3 2018 | $61,210,000 | +28.2% | 534,205 | +0.3% | 0.04% | +17.1% |
| Q2 2018 | $47,764,000 | +38.2% | 532,599 | +12.7% | 0.04% | +29.6% |
| Q1 2018 | $34,566,000 | +7.3% | 472,464 | -14.8% | 0.03% | +3.8% |
| Q4 2017 | $32,215,000 | +21.8% | 554,652 | -5.9% | 0.03% | +13.0% |
| Q3 2017 | $26,446,000 | +17.8% | 589,379 | +3.7% | 0.02% | +9.5% |
| Q2 2017 | $22,449,000 | +1.7% | 568,454 | +4.5% | 0.02% | -4.5% |
| Q1 2017 | $22,071,000 | +22.0% | 544,003 | +20.9% | 0.02% | +10.0% |
| Q4 2016 | $18,093,000 | +26.2% | 450,055 | +13.7% | 0.02% | +17.6% |
| Q3 2016 | $14,337,000 | +5.8% | 395,925 | -15.3% | 0.02% | 0.0% |
| Q2 2016 | $13,548,000 | +49.4% | 467,303 | +80.3% | 0.02% | +41.7% |
| Q1 2016 | $9,067,000 | +30.3% | 259,202 | +20.1% | 0.01% | +33.3% |
| Q4 2015 | $6,958,000 | +2.2% | 215,800 | +2.5% | 0.01% | -10.0% |
| Q3 2015 | $6,807,000 | -16.6% | 210,598 | +6.7% | 0.01% | -9.1% |
| Q2 2015 | $8,164,000 | -1.2% | 197,371 | +7.3% | 0.01% | -8.3% |
| Q1 2015 | $8,266,000 | +27.8% | 183,994 | +6.5% | 0.01% | +20.0% |
| Q4 2014 | $6,467,000 | +11.0% | 172,812 | +3.6% | 0.01% | 0.0% |
| Q3 2014 | $5,824,000 | -0.6% | 166,760 | +0.4% | 0.01% | 0.0% |
| Q2 2014 | $5,860,000 | +11.0% | 166,099 | +2.5% | 0.01% | +11.1% |
| Q1 2014 | $5,280,000 | -24.3% | 161,989 | -2.1% | 0.01% | -30.8% |
| Q4 2013 | $6,971,000 | +8.8% | 165,457 | +3.1% | 0.01% | 0.0% |
| Q3 2013 | $6,409,000 | -1.0% | 160,425 | +5.1% | 0.01% | -7.1% |
| Q2 2013 | $6,474,000 | – | 152,577 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |